Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hao‐Xian Zhu
Observed name:
Hao-Xian Zhu
Institutions:
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University,
South China University of Technology
Observed institutions:
Guangzhou First People's Hospital,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University,
South China University of Technology
ORCID:
0000-0003-3363-7983
Observed ORCID:
0000-0003-3363-7983
OpenAlex ID:
A5017211449
Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases
2019
·
Chuan Huang
, Hao-Xian Zhu
, et al.
·
Journal of Autoimmunity
·
101
Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+ T cells in primary Sjögren’s syndrome
2023
·
Ting Xu
, Hao-Xian Zhu
, et al.
·
JCI Insight
·
97
PDF
Targeting pathogenic CD8+ tissue-resident T cells with chimeric antigen receptor therapy in murine autoimmune cholangitis
2024
·
Hao-Xian Zhu
, Shu-Han Yang
, et al.
·
Nature Communications
·
52
PDF
PD‐1 + CD8 + T Cell‐Mediated Hepatocyte Pyroptosis Promotes Progression of Murine Autoimmune Liver Disease
2024
·
Jie Long
, Si‐Yu Yang
, et al.
·
Advanced Science
·
24
PDF
Identification of Pathogenic PD ‐1+ CD8 + T Cells for Effective Chimeric Antigen Receptor Therapy in a Murine Model of Sjögren Disease
2025
·
Jin‐Fen Ma
, Ting Xu
, et al.
·
Arthritis & Rheumatology
·
7
Single-cell profiling reveals clonal CD8+T cell-derived IFNγ drives Sjögren’s disease-related dacryoadenitis
2026
·
Hao-Xian Zhu
, Fang-Fang Li
, et al.
·
Inflammation Research
·
2
Show more works
View as search
Works count:
6
Citation count:
283
H-index:
5
I10-index:
4
Year
Topic
Type